8-K: Intuitive Surgical Announces Strong Preliminary Q4 and Full Year 2024 Results, da Vinci Procedures Up 17%

Intuitive Surgical reports preliminary Q4 and full year 2024 results, highlighting significant revenue growth and increased da Vinci surgical system placements and procedures.

Summary

• Intuitive Surgical announced preliminary unaudited financial results for the fourth quarter and full year 2024.
• Fourth quarter revenue is expected to be approximately $2.41 billion, a 25% increase compared to $1.93 billion in the fourth quarter of 2023.
• Full year 2024 revenue is expected to be approximately $8.35 billion, a 17% increase compared to $7.12 billion in 2023.
• Worldwide da Vinci procedures grew approximately 18% in the fourth quarter and 17% for the full year.
• The company placed 493 da Vinci systems in Q4 2024, including 174 da Vinci 5 systems, a 19% increase from 415 systems in Q4 2023.
• For the full year 2024, 1,526 da Vinci systems were placed, including 362 da Vinci 5 systems, an 11% increase from 1,370 systems in 2023.
• The company expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results and growth in key metrics, indicating a healthy and expanding business. However, the preliminary nature of the results and the presence of risk factors temper the overall sentiment.

Positives

• Strong revenue growth in both Q4 2024 and full year 2024.
• Significant increase in da Vinci system placements, including the new da Vinci 5.
• Continued growth in da Vinci procedure volume, both in the U.S. and internationally.
• Increased adoption of da Vinci 5, Ion, and SP systems.
• No significant procedure volume disruptions due to COVID-19 in 2024.

Negatives

• The preliminary results are unaudited and subject to change.
• The company expects da Vinci procedure growth to slow down to 13%-16% in 2025 compared to 17% in 2024.

Risks

• The preliminary financial results are subject to final audit and adjustments.
• Future results are subject to various risks and uncertainties, including macroeconomic conditions, supply chain disruptions, regulatory approvals, and competition.
• The company's reliance on sole and single sourced suppliers could pose a risk.
• Adverse publicity regarding the company and the safety of its products could impact future performance.

Future Outlook

The company expects worldwide da Vinci procedures to increase approximately 13% to 16% in 2025.

Management Comments

• Intuitive CEO Gary Guthart stated, 'We are pleased with customer adoption of da Vinci 5, Ion, and SP during the quarter and full year. We remain focused on delivering the goals we share with our customers, centered on improving patient outcomes.'

Industry Context

The announcement reflects Intuitive Surgical's continued dominance in the robotic-assisted surgery market, driven by innovation and increasing adoption of its da Vinci systems. The growth in procedures and system placements indicates a positive trend in minimally invasive surgery.

Comparison to Industry Standards

• Intuitive Surgical's growth in da Vinci procedures and system placements outpaces the overall growth rate of the surgical robotics market, suggesting a gain in market share.
• Globally, companies like Stryker, Medtronic, and Johnson & Johnson are also investing in surgical robotics, but Intuitive Surgical maintains a leading position with its established da Vinci platform.
• The placement of 362 da Vinci 5 systems in 2024 indicates strong initial adoption of the new platform, which could further solidify Intuitive's competitive advantage.

Stakeholder Impact

• Shareholders will likely react positively to the strong financial results and growth prospects.
• Hospitals and surgeons benefit from the advanced technology and training provided by Intuitive Surgical.
• Patients benefit from minimally invasive surgical options and improved outcomes.

Next Steps

• The company will present at the 2025 J.P. Morgan Healthcare Conference on January 15, 2025.
• The company will report its fourth quarter 2024 results during a conference call on January 23, 2025.

Key Dates